In 1997, Itzhaki and colleagues first provided strong evidence for a linkage between HSV 1 infection and AD, supporting that the reactivation of HSV 1 in the central nervous system is more harmful in AD patients who carry the APOE-ε4 allele and that the combination of these two factors increases the likelihood of disease [21]. This evidence concerns the gene APOE and Alzheimer disease.